USANA Health Sciences, Inc.USNANYSE
Loading
Enterprise value to EBITDA ratio
3Y CAGR
-25.4%/yr
vs -19.3%/yr prior
5Y CAGR
-18.4%/yr
Recent deceleration
Acceleration
-6.0pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.39 | -56.0% |
| 2024 | 5.44 | -6.3% |
| 2023 | 5.80 | +0.8% |
| 2022 | 5.76 | -38.9% |
| 2021 | 9.42 | +42.2% |
| 2020 | 6.62 | -28.7% |
| 2019 | 9.29 | -31.7% |
| 2018 | 13.59 | +17.6% |
| 2017 | 11.56 | +32.9% |
| 2016 | 8.70 | - |